5'-O-[N-(11-Phenoxyundecyl)sulfamoyl]adenosine

ID: ALA4794644

Chembl Id: CHEMBL4794644

PubChem CID: 162672877

Max Phase: Preclinical

Molecular Formula: C27H40N6O7S

Molecular Weight: 592.72

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NCCCCCCCCCCCOc2ccccc2)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C27H40N6O7S/c28-25-22-26(30-18-29-25)33(19-31-22)27-24(35)23(34)21(40-27)17-39-41(36,37)32-15-11-6-4-2-1-3-5-7-12-16-38-20-13-9-8-10-14-20/h8-10,13-14,18-19,21,23-24,27,32,34-35H,1-7,11-12,15-17H2,(H2,28,29,30)/t21-,23-,24-,27-/m1/s1

Standard InChI Key:  DOWWLAIXNKDBSW-VBHAUSMQSA-N

Alternative Forms

  1. Parent:

    ALA4794644

    ---

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
fadD19 PROBABLE FATTY-ACID-CoA LIGASE FADD19 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
fadD28 Acyl-CoA synthase (418 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 592.72Molecular Weight (Monoisotopic): 592.2679AlogP: 2.47#Rotatable Bonds: 18
Polar Surface Area: 183.94Molecular Species: NEUTRALHBA: 12HBD: 4
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.32CX Basic pKa: 4.92CX LogP: 2.95CX LogD: 2.95
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.16Np Likeness Score: 0.20

References

1. Baran M,Grimes KD,Sibbald PA,Fu P,Boshoff HIM,Wilson DJ,Aldrich CC.  (2020)  Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.,  201  [PMID:32574901] [10.1016/j.ejmech.2020.112408]

Source